Adoptive cell therapy for patients with melanoma, using tumor-infiltrating lymphocytes genetically engineered to secrete interleukin-2.

Source:http://linkedlifedata.com/resource/pubmed/id/18444786

Download in:

View as

General Info

PMID
18444786